Evaluation of Anti-Tetanus Immunity in Haemodialysis Patients

Problem statement: The incidence of infectious diseases is increased in patients with chronic renal failure. Chronic renal failure severely influences the immune functions of the host. Approach: To evaluate the antitetanus immunity level in southern Iranian patients with end stage renal disease undergoing hemodialysis and to find its association with sex, age, blood hemoglobin and serum albumin, duration of dialysis. This cross sectional study was carried out on a total of 52 patients, who were on hemodialysis and 52 age and sex matched healthy individuals with without any underlying renal disease as a control group. Individuals in the both groups receiving antitetanus toxoid vaccine or immunoglubins a year prior to the study were excluded. The serum antitetanus IgG antibody levels were measured by an ELISA method. Results: Tetanus protected individuals in the patients and the control groups were 34.6 and 63.30% respectively. Of the evaluating factors just hemodialysis duration found to affect on tetanus immunity. Conclusion: Tetanus protected individuals in the patients group were significantly less than tetanus protected individuals in the control group (p = 0.011). Hemodialysis duration has significant effect on antitetanus immunity level.

[1]  N. Litjens,et al.  Impaired immune responses and antigen-specific memory CD4+ T cells in hemodialysis patients. , 2008, Journal of the American Society of Nephrology : JASN.

[2]  M. Sagheb,et al.  Antitetanus toxoid antibody titer of chronic hemodialysis patients in Iran. , 2008, Iranian journal of immunology : IJI.

[3]  Y. Berland,et al.  Natural killer cell alterations correlate with loss of renal function and dialysis duration in uraemic patients. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  G. Russ,et al.  Uremia impairs monocyte and monocyte-derived dendritic cell function in hemodialysis patients. , 2007, Kidney international.

[5]  M. Ghazanfari,et al.  Immunogenicity of a triple diphtheria-tetanus-whole cell pertussis vaccine in Iranian preschool children. , 2007, Iranian journal of immunology : IJI.

[6]  D. Gilbertson,et al.  Overview of vaccination in chronic kidney disease. , 2006, Advances in chronic kidney disease.

[7]  H. Argani,et al.  Levamizole enhances immune responsiveness to intra-dermal and intra-muscular hepatitis B vaccination in chronic hemodialysis patients , 2006, Journal of immune based therapies and vaccines.

[8]  J. Storsaeter,et al.  Is there a need for a new generation of vaccines against pertussis? , 2006, Expert opinion on emerging drugs.

[9]  Kaliuzhina Ev,et al.  The condition of immune homeostasis in patients with chronic renal failure , 2006 .

[10]  V. V. Kaliuzhin,et al.  [The condition of immune homeostasis in patients with chronic renal failure]. , 2006, Klinicheskaia meditsina.

[11]  S. Wessely,et al.  Analysis of Anthrax and Plague Biowarfare Vaccine Interactions with Human Monocyte-Derived Dendritic Cells1 , 2005, The Journal of Immunology.

[12]  J. Taranger,et al.  Diphtheria, tetanus and pertussis antibodies in 10-year-old children before and after a booster dose of three toxoids: implications for the timing of a booster dose , 2005, European Journal of Pediatrics.

[13]  L. Rink,et al.  The impaired immune response to diphtheria vaccinationin elderly chronic hemodialysis patients is related to zinc deficiency , 2004, Biogerontology.

[14]  Releve Epidemiologique Hebdomadaire.  Relevé épidémiologique hebdomadaire , 2003 .

[15]  R. Koff.  Immunogenicity of hepatitis B vaccines: implications of immune memory. , 2002, Vaccine.

[16]  A. Mackensen,et al.  Analysis of the immune response against tetanus toxoid: enumeration of specific T helper cells by the Elispot assay. , 2002, Immunobiology.

[17]  H. Kirchner,et al.  A 5-year follow-up on antibody response after diphtheria and tetanus vaccination in hemodialysis patients. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[18]  M. Kundi,et al.  Antibody-response to three recombinant hepatitis B vaccines: comparative evaluation of multicenter travel-clinic based experience. , 2001, Vaccine.

[19]  J. Ślusarczyk.  Who needs vaccination against hepatitis viruses? , 2000, Vaccine.

[20]  K. Sack,et al.  Defective immune response to tetanus toxoid in hemodialysis patients and its association with diphtheria vaccination. , 1999, Vaccine.

[21]  P. Bonanni.  Universal hepatitis B immunization: infant, and infant plus adolescent immunization. , 1998, Vaccine.

[22]  V. Grey,et al.  Specific antibody responses to diphtheria/tetanus revaccination in children evaluated for immunodeficiency. , 1997, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[23]  P. Bartmann,et al.  Response to diphtheria and tetanus booster vaccination in pediatric renal transplant recipients. , 1997, Transplantation.

[24]  P. Gergen,et al.  A population-based serologic survey of immunity to tetanus in the United States. , 1995, The New England journal of medicine.

[25]  M. Girndt,et al.  Tetanus immunization and its association to hepatitis B vaccination in patients with chronic renal failure. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[26]  S. Görg,et al.  [Sex and age-dependent gaps in tetanus immunization]. , 2008, Deutsche medizinische Wochenschrift.

[27]  B. Fleischer,et al.  T cell activation defect in hemodialysis patients: evidence for a role of the B7/CD28 pathway. , 1993, Kidney international.

[28]  A. Guérin,et al.  Response to vaccination against tetanus in chronic haemodialysed patients. , 1992, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[29]  M. Broyer,et al.  Serum antibodies before and after immunisation in haemodialysed children. , 1977, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association.